AI-Driven Spatial Biomarker Discovery in the Tumor Microenvironment

Ali Almahmoud

Ali Almahmoud Independent Researcher, Lebanon

Keywords: Tumor Microenvironment, Deep Learning, Explainable AI, Immunotherapy Response Prediction, Digital Pathology

Abstract

How a cancer develops and how well it responds to treatment isn't just about the cancer cells themselves anymore; the area around the tumour (the tumour microenvironment) is now understood to be hugely important, and this includes how the cells are organised within the tissue. As we’ve learned more about the location of cells in a tissue from recent developments in spatial biology, we've seen that where immune cells and cancer cells are in relation to each other, and how they interact, greatly affects how the disease will go (Erasha et al., 2025; Williams et al., 2024). Spatial biomarkers - which are defined by where cells are, how many of each type are in an area, and how they’re positioned next to each other - give a much more detailed and accurate prediction of what will happen compared to the usual ‘bulk’ biomarkers (Faktor et al., 2024).

Using artificial intelligence (AI) with this spatial analysis has really sped up the finding of biomarkers, because it’s able to pick out complicated patterns from a lot of information from images and what genes are being used. Machine learning and deep learning methods help us to find spatial patterns linked to immune cell movement into the tumour, how different the tumour cells are from each other, and resistance to treatments (Nguyen et al., 2021; Xu et al., 2024). Spatial transcriptomics and looking at digital pathology images are the foundations for this, providing the data for AI to work out what cells are near which others and what those relationships mean for biology (Du et al., 2023; Jin et al., 2024).

What’s particularly exciting is that using AI to find these spatial biomarkers is showing great promise for predicting whether a treatment will work, especially with immunotherapies. We can now categorize tumours as either “hot” or “cold” for immune activity, and we can find patterns of keeping immune cells out of the tumour. These both improve how we decide which patients to treat in which ways (Melssen et al., tually, and therapeutic decisions (Melssen et al., 2023; Zuo et al., 2020). Moreover, newer computer programs that use graph-based methods and combine multiple kinds of data are making the predictions even more accurate and useful in the clinic (Kong et al., 2021; Mallya et al., 2025).

Even with all this progress, difficulties still exist: the data can be quite variable, it can be tricky to understand how the AI models are working, and we definitely need solid tests in the clinic to confirm the findings. However, the coming together of AI and spatial biology is completely changing cancer research, providing a level of understanding of how the tumour and the immune system interact that we haven't had before, and opening the door for treatment plans designed for each individual's specific tumour's spatial characteristics.

References

Amer, H. T., Stein, U., & El Tayebi, H. M. (2022, November 1). The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer. Cancers. MDPI. https://doi.org/10.3390/cancers14215460
Bracken, A., Reilly, C., Feeley, A., Sheehan, E., Merghani, K., & Feeley, I. (2025, December 1). Artificial Intelligence (AI) – Powered Documentation Systems in Healthcare: A Systematic Review. Journal of Medical Systems. Springer. https://doi.org/10.1007/s10916-025-02157-4
Chen, W. T., Lu, A., Craessaerts, K., Pavie, B., Sala Frigerio, C., Corthout, N., … De Strooper, B. (2020). Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease. Cell, 182(4), 976-991.e19. https://doi.org/10.1016/j.cell.2020.06.038
Cornice, J., Verzella, D., Arboretto, P., Vecchiotti, D., Capece, D., Zazzeroni, F., & Franzoso, G. (2024, February 1). NF-κB: Governing Macrophages in Cancer. Genes. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/genes15020197
DiPalma, M. P., & Blattman, J. N. (2023). The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME). Frontiers in Cell and Developmental Biology. Frontiers Media S.A. https://doi.org/10.3389/fcell.2023.1141215
Du, J., Yang, Y. C., An, Z. J., Zhang, M. H., Fu, X. H., Huang, Z. F., … Hou, J. (2023, December 1). Advances in spatial transcriptomics and related data analysis strategies. Journal of Translational Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12967-023-04150-2
Erasha, A. M., El-Gendy, H., Aly, A. S., Fernández-Ortiz, M., & Sayed, R. K. A. (2025). The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes. International Journal of Molecular Sciences, 26(6). https://doi.org/10.3390/IJMS26062716
Faktor, J., Kote, S., Bienkowski, M., Hupp, T. R., & Marek-Trzonkowska, N. (2024). Novel FFPE proteomics method suggests prolactin-induced protein as a hormone-induced cytoskeleton remodeling spatial biomarker. Communications Biology, 7(1). https://doi.org/10.1038/s42003-024-06354-8
Haleem, A., Javaid, M., Asim Qadri, M., Pratap Singh, R., & Suman, R. (2022, January 1). Artificial intelligence (AI) applications for marketing: A literature-based study. International Journal of Intelligent Networks. KeAi Communications Co. https://doi.org/10.1016/j.ijin.2022.08.005
Han, S., & Wu, J. (2024). Artificial intelligence (AI) meets biomaterials and biomedicine. Smart Materials in Medicine, 5(2), 251–255. https://doi.org/10.1016/j.smaim.2024.03.001
Hong, M., Clubb, J. D., & Chen, Y. Y. (2020, October 12). Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccell.2020.07.005
Horodyski, P. (2023). Recruiter’s perception of artificial intelligence (AI)-based tools in recruitment. Computers in Human Behavior Reports, 10. https://doi.org/10.1016/j.chbr.2023.100298
Jin, Y., Zuo, Y., Li, G., Liu, W., Pan, Y., Fan, T., … Peng, Y. (2024, December 1). Advances in spatial transcriptomics and its applications in cancer research. Molecular Cancer. BioMed Central Ltd. https://doi.org/10.1186/s12943-024-02040-9
Kong, Y., Gao, S., Yue, Y., Hou, Z., Shu, H., Xie, C., … Yuan, Y. (2021). Spatio-temporal graph convolutional network for diagnosis and treatment response prediction of major depressive disorder from functional connectivity. Human Brain Mapping, 42(12), 3922–3933. https://doi.org/10.1002/hbm.25529
Krull, D., Haynes, P., Kesarwani, A., Tessier, J., Chen, B. J., Hunter, K., … Anguiano, E. (2025). A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort studies using digital spatial profiling. Journal of Histotechnology, 48(1), 7–26. https://doi.org/10.1080/01478885.2024.2391683
Li, N., Zhang, N., & Wang, G. (2025). Overexpression of MMP14 is associated with poor prognosis and immune cell infiltration in colon cancer. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1564375
Li, R., Li, N., Yang, Q., Tong, X., Wang, W., Li, C., … Feng, Y. (2024). Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis. Genome Medicine, 16(1). https://doi.org/10.1186/s13073-024-01422-4
Mallya, M., Mirabadi, A. K., Farnell, D., Farahani, H., & Bashashati, A. (2025). Benchmarking histopathology foundation models for ovarian cancer bevacizumab treatment response prediction from whole slide images. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-01973-x
Melssen, M. M., Sheybani, N. D., Leick, K. M., & Slingluff, C. L. (2023, April 18). Barriers to immune cell infiltration in tumors. Journal for ImmunoTherapy of Cancer. BMJ Publishing Group. https://doi.org/10.1136/jitc-2022-006401
Mohd Amin, M. R., Ismail, I., & Sivakumaran, V. M. (2025, January 1). Revolutionizing Education with Artificial Intelligence (AI)? Challenges and Implications for Open and Distance Learning (ODL). Social Sciences and Humanities Open. Elsevier Ltd. https://doi.org/10.1016/j.ssaho.2025.101308
Mu, Q., & Najafi, M. (2021, September 15). Modulation of the tumor microenvironment (TME) by melatonin. European Journal of Pharmacology. Elsevier B.V. https://doi.org/10.1016/j.ejphar.2021.174365
Nguyen, T. M., Kim, N., Kim, D. H., Le, H. L., Piran, M. J., Um, S. J., & Kim, J. H. (2021, November 1). Deep learning for human disease detection, subtype classification, and treatment response prediction using epigenomic data. Biomedicines. MDPI. https://doi.org/10.3390/biomedicines9111733
Su, J., & Zhong, Y. (2022). Artificial Intelligence (AI) in early childhood education: Curriculum design and future directions. Computers and Education: Artificial Intelligence, 3. https://doi.org/10.1016/j.caeai.2022.100072
Vaishya, R., Javaid, M., Khan, I. H., & Haleem, A. (2020). Artificial Intelligence (AI) applications for the COVID-19 pandemic. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(4), 337–339. https://doi.org/10.1016/j.dsx.2020.04.012
Wang, C., Zhang, R., Zhang, J., Ren, Y., Pang, T., Chen, X., … Yu, Y. (2025). Multi-feature fusion RFE random forest for schizophrenia classification and treatment response prediction. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-89359-5
Wiese, J. J., Manna, S., Kühl, A. A., Fascì, A., Elezkurtaj, S., Sonnenberg, E., … Schumann, M. (2024). Myenteric Plexus Immune Cell Infiltrations and Neurotransmitter Expression in Crohn’s Disease and Ulcerative Colitis. Journal of Crohn’s and Colitis, 18(1), 121–133. https://doi.org/10.1093/ecco-jcc/jjad122
Williams, H. L., Frei, A. L., Koessler, T., Berger, M. D., Dawson, H., Michielin, O., & Zlobec, I. (2024, December 1). The current landscape of spatial biomarkers for the prediction of response to immune checkpoint inhibition. Npj Precision Oncology. Nature Research. https://doi.org/10.1038/s41698-024-00671-1
Xu, H., Fu, H., Long, Y., Ang, K. S., Sethi, R., Chong, K., … Chen, J. (2024). Unsupervised spatially embedded deep representation of spatial transcriptomics. Genome Medicine, 16(1). https://doi.org/10.1186/s13073-024-01283-x
Yang, P., Yang, W., Wei, Z., Li, Y., Yang, Y., & Wang, J. (2023, July 1). Novel targets for gastric cancer: The tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis, and cuproptosis. Biomedicine and Pharmacotherapy. Elsevier Masson s.r.l. https://doi.org/10.1016/j.biopha.2023.114883
Zuo, S., Wei, M., Wang, S., Dong, J., & Wei, J. (2020). Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01218